🚀 Healthcare Technology — Last 24 Hours
Compiled: Aug 19, 2025 (America/Los_Angeles)
1) Epic rolls out MyChart Central for one-login patient access
Epic announced MyChart Central, a new patient-focused login that lets people access records from multiple participating providers using a single Epic ID — a step toward simpler cross-org patient access and fewer portal passwords. Read more.
2) “EHR tune-ups” touted to boost clinical performance
A fresh Becker’s analysis argues many hospitals aren’t extracting full value from their core EHR and recommends periodic “EHR tune-ups” to close gaps between clinical workflow and system configuration — quick wins before big-bang upgrades. Read more.
3) Grow Therapy launches AI-powered patient journaling
Hybrid mental-health provider Grow Therapy introduced AI-assisted journaling to keep patients engaged between sessions — a lightweight way to extend care and capture context clinicians can review. Read more.
4) Medtronic lifts profit outlook as tariff impact eases
Medical-device giant Medtronic raised its annual profit forecast on lower tariff effects — a macro tailwind for device makers that could accelerate capital plans for imaging, robotics, and cardiac tech. Read more.
5) Viking’s weight-loss pill misses top expectations in mid-stage study
Viking Therapeutics reported 12.2% mean weight loss with its oral pill in Phase 2 — below the Street’s high end — sending shares lower and underscoring the bar set by injectable competitors as obesity therapeutics reshape digital-health and cardiometabolic care pathways. Read more.
Why It Matters
- Patient access: MyChart Central reduces portal sprawl and may boost engagement and health-information exchange.
- Operational hygiene: EHR tune-ups often beat rip-and-replace — align build with actual clinical workflows first.
- Behavioral-health UX: Small AI features (journaling) can compound adherence and outcomes between visits.
- Device macro: Improved outlooks at large med-techs can translate into faster refresh cycles inside hospitals.
- Obesity pipeline reality: Oral GLP-1 contenders face a high efficacy bar; digital and RPM programs should plan accordingly.
